|
Anterior nerve cell disease
Citations 71-80 of 109 total displayed.
|
Past content
(since Jan 2001):
|
- BRIEF COMMUNICATIONS
Placebo-controlled phase I/II studies of minocycline in amyotrophic lateral sclerosis
- P. H. Gordon, D. H. Moore, D. F. Gelinas, C. Qualls, M. E. Meister, J. Werner, M. Mendoza, J. Mass, G. Kushner, and R. G. Miller
Neurology 2004; 62: 1845-1847.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
HFE mutations are not strongly associated with sporadic ALS
- A. A. Yen, E. P. Simpson, J. S. Henkel, D. R. Beers, and S. H. Appel
Neurology 2004; 62: 1611-1612.
[Abstract]
[Full text]
[PDF]
- EDITORIALS
ALS: Persistent scientists do not find persisting enteroviruses
- Burk Jubelt and Howard L. Lipton
Neurology 2004; 62: 1250-1251.
[Full text]
[PDF]
- ARTICLES
Failure to detect enterovirus in the spinal cord of ALS patients using a sensitive RT-PCR method
- W. A. Nix, M. M. Berger, M. S. Oberste, B. R. Brooks, D. M. McKenna-Yasek, R. H. Brown, Jr., R. P. Roos, and M. A. Pallansch
Neurology 2004; 62: 1372-1377.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Magnetic resonance imaging of thoracic epidural venous dilation in Hirayama disease
- Y. Baba, M. Nakajima, H. Utsunomiya, Y. Tsuboi, F. Fujiki, T. Kusuhara, and T. Yamada
Neurology 2004; 62: 1426-1428.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Large-scale disruption of microtubule pathways in morphologically normal human spastin muscle
- A. Molon, S. Di Giovanni, Y. W. Chen, P. M. Clarkson, C. Angelini, E. Pegoraro, and E. P. Hoffman
Neurology 2004; 62: 1097-1104.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
The "split hand" phenomenon: Evidence of a spinal origin
- H. J. Schelhaas, B. P.C. van de Warrenburg, H. P.H. Kremer, and M. J. Zwarts
Neurology 2003; 61: 1619-1620.
[Abstract]
[Full text]
[PDF]
- CLINICAL/SCIENTIFIC NOTES
"Myorhythmia" slow facial tremor from chronic interferon alpha-2a usage
- Eng-King Tan, Ling-Ling Chan, and Yew-Long Lo
Neurology 2003; 61: 1302-1303.
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Riluzole serum concentrations in patients with ALS: Associations with side effects and symptoms
- G. J. Groeneveld, H. J.M. Van Kan, S. Kalmijn, J. H. Veldink, H.-J. Guchelaar, J. H.J. Wokke, and L. H. Van den Berg
Neurology 2003; 61: 1141-1143.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Biomagnification of cycad neurotoxins in flying foxes: Implications for ALS-PDC in Guam
- Sandra Anne Banack and Paul Alan Cox
Neurology 2003; 61: 387-389.
[Abstract]
[Full text]
[PDF]
|
|